Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,613 | -2,160 | -11,911 | -9,493 | -6,903 |
| Depreciation Amortization | 34 | 17 | 68 | 51 | 34 |
| Accounts payable and accrued liabilities | 538 | -3 | 129 | 417 | 363 |
| Other Working Capital | 309 | -302 | 635 | 421 | 686 |
| Other Operating Activity | 963 | 805 | 2,842 | 1,804 | 1,171 |
| Operating Cash Flow | $-2,769 | $-1,643 | $-8,237 | $-6,800 | $-4,649 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,101 | 2,101 | 2,101 |
| Investing Cash Flow | $0 | $N/A | $2,101 | $2,101 | $2,101 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,898 | 1,898 | N/A | 0 | N/A |
| Financing Cash Flow | $1,898 | $1,898 | $N/A | $0 | $N/A |
| Beginning Cash Position | 10,479 | 10,479 | 16,615 | 16,615 | 16,615 |
| End Cash Position | 9,608 | 10,734 | 10,479 | 11,916 | 14,067 |
| Net Cash Flow | $-871 | $255 | $-6,136 | $-4,699 | $-2,548 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,769 | -1,643 | -8,237 | -6,800 | -4,649 |
| Free Cash Flow | -2,769 | -1,643 | -8,237 | -6,800 | -4,649 |